Literature DB >> 20600026

The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer.

Harminder Singh1, Zoann Nugent, Alain A Demers, Erich V Kliewer, Salaheddin M Mahmud, Charles N Bernstein.   

Abstract

BACKGROUND & AIMS: There are limited data on mortality from colorectal cancer (CRC) among patients who have received colonoscopy examinations. We sought to determine CRC mortality among persons undergoing colonoscopies compared with the general population.
METHODS: We identified all individuals who had a colonoscopy as their first lower gastrointestinal endoscopy from April 1, 1987, to September 30, 2007 (24,342 men and 30,461 women), based on information from Manitoba's provincial physicians' billing claims database. Patients were followed until March 31, 2008, death, or migration out of the province (310,718 person-years). Individuals less than 50 years of age or more than 80 years of age at the index colonoscopy or those with prior sigmoidoscopy, inflammatory bowel disease, resective colorectal surgery, or CRC were excluded. CRC mortality after the index colonoscopy was compared with that of the general population by standardized mortality ratios (SMRs). Stratified analyses were performed to determine CRC mortality for different age groups at index colonoscopy and sex, duration of follow-up, medical specialty of the endoscopist, and site of CRC.
RESULTS: There was a 29% reduction in overall CRC mortality (SMR, 0.71; 95% confidence interval [CI], 0.61-0.82], a 47% reduction in mortality from distal CRC (SMR, 0.53; 95% CI, 0.42-0.67), and no reduction in mortality from proximal CRC (SMR, 0.94; 95% CI, 0.77-1.17). The reduction in mortality from distal CRC remained significant for follow-up beyond 10 years (SMR, 0.53; 95% CI, 0.31-0.84).
CONCLUSIONS: In Manitoba, colonoscopies significantly reduce mortality from CRC, but the benefit is not uniform for colorectal tumors that arise in different areas of the colon.
Copyright © 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20600026     DOI: 10.1053/j.gastro.2010.06.052

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  178 in total

1.  Treatment of alcoholic methadone-maintenance patients with disulfiram.

Authors:  A Pugliese; M Martinez; A Maselli; D H Zalick
Journal:  J Stud Alcohol       Date:  1975-11

2.  Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty.

Authors:  Nancy N Baxter; Joan L Warren; Michael J Barrett; Therese A Stukel; V Paul Doria-Rose
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

3.  Light-scattering technologies for field carcinogenesis detection: a modality for endoscopic prescreening.

Authors:  Vadim Backman; Hemant K Roy
Journal:  Gastroenterology       Date:  2010-11-12       Impact factor: 22.682

4.  Patient- and procedure-related factors affecting proximal and distal detection rates for polyps and adenomas: results from 1603 screening colonoscopies.

Authors:  Christoph Schramm; Nadine Mbaya; Jeremy Franklin; Muenevver Demir; Fabian Kuetting; Ulrich Toex; Tobias Goeser; Hans-Michael Steffen
Journal:  Int J Colorectal Dis       Date:  2015-08-15       Impact factor: 2.571

5.  The use of an optimized colonoscopy protocol in a low-risk population for colorectal cancer prevention.

Authors:  Swathi Eluri; Seth D Crockett; John A Baron
Journal:  Int J Cancer       Date:  2015-02-24       Impact factor: 7.396

Review 6.  Colorectal cancer screening--optimizing current strategies and new directions.

Authors:  Ernst J Kuipers; Thomas Rösch; Michael Bretthauer
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

Review 7.  Colorectal cancer screening quality, cost and practice in an era of healthcare transformation.

Authors:  Martin Brotman
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

8.  Assessing the effectiveness of a cancer screening test in the presence of another screening modality.

Authors:  Jessica Chubak; Rebecca A Hubbard; Eric Johnson; Aruna Kamineni; Carolyn M Rutter
Journal:  J Med Screen       Date:  2014-12-09       Impact factor: 2.136

9.  Quality indicators for colorectal cancer screening for colonoscopy.

Authors:  Philip S Schoenfeld; Jonathan Cohen
Journal:  Tech Gastrointest Endosc       Date:  2013-04

Review 10.  A unified model for left-right asymmetry? Comparison and synthesis of molecular models of embryonic laterality.

Authors:  Laura N Vandenberg; Michael Levin
Journal:  Dev Biol       Date:  2013-04-10       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.